Primary record
Oral kinase activator (theraTRACE, oral, type 2 diabetes), Melior
- 库存
- 9,240 克
- 纯度
- 98.6 %
- CAS
- 41964-07-2
化合物标识与属性
- CAS
- 41964-07-2
- PubChem CID
- 39065
- SMILES
- CC1=CC(=CC=C1)OC2=CNC(=O)N=C2
- Canonical SMILES
- Cc1cccc(Oc2cnc(=O)[nH]c2)c1
名称与同义词
- TOLIMIDONE
- MLR-1023
- 41964-07-2
- Tolimidona
- 5-(m-tolyloxy)pyrimidin-2(1H)-one
- Tolimidone (USAN)
- MU3JD8E9IS
- CP-26154
- Tolimidone [USAN:INN]
- 5-(3-methylphenoxy)-1H-pyrimidin-2-one
- UNII-MU3JD8E9IS
- MLR 1023
- 5-(3-methylphenoxy)-2(1h)-pyrimidinone
- TOLIMIDONE [INN]
- RefChem:190291
- TOLIMIDONE [USAN]
- MFCD00866900
- D0ZU4U
- AC1L20ZP
- CHEMBL8030
- Tolimidone (MLR-1023)
- TOLIMIDONE [WHO-DD]
- 7-(Trifluoromethyl)quinoline
- MLR-1003
- MLS006012600
- 5-m-Tolyloxy-pyrimidin-2-ol
- NSC-314335
- SCHEMBL637505
- 2(1H)-Pyrimidinone, 5-(3-methylphenoxy)-
- DTXSID50194786
- QCR-285
- C11H10N2O2
- CP-26,154
- GTPL9433
- orb1300367
- O(c1cnc(O)nc1)c2cccc(C)c2
- SCHEMBL21168610
- SCHEMBL31396447
- AOB1019
- DTXCID90117277
- SYN5050
- GLXC-02728
- HMS3749I15
- 5-(3-methylphenoxy)pyrimidin-2-ol
- BCP06813
- CID39065
- EX-A1338
- RBA96407
- BDBM50545405
- CID:39065
- EBC-50110
- NSC314335
- s8321
- ZINC17120697
- 5-(m-Tolyloxy)-2(1H)-pyrimidinone
- CP 26154
- AKOS000282153
- CCG-266597
- CS-7936
- NSC 314335
- SB17288
- NCGC00370768-01
- NCGC00370768-04
- 5-(3-methylphenoxy)pyrimidin-2(1H)-one
- AC-37077
- AJ-69962
- AS-16416
- DA-78528
- HY-59047
- J16.876I
- SMR004704144
- SID:405116799
- 5-(3-Methylphenoxy)- 2(1H)-pyrimidinone
- B5648
- MLR-1023, >=98% (HPLC)
- NS00125071
- A12417
- D06182
- L-2205
- 5-(3-methylphenoxy)-1,2-dihydropyrimidin-2-one
- EN300-1599855
- 5-(3-Methylphenoxy)-2(1H)-pyrimidinone, 95+%
- A899682
- C576397
- Q7814266
- BRD-K41772907-001-01-2
- BRD-K41772907-001-02-0
- Oral kinase activator (theraTRACE, oral, type 2 diabetes), Melior
- 74078-86-7